Cystic Fibrosis Foundation - 15 May 2024 Form 4 Insider Report for BiomX Inc. (PHGE)

Role
10%+ Owner
Signature
/s/ Ania Howell
Issuer symbol
PHGE
Transactions as of
15 May 2024
Net transactions value
+$4,778
Form type
4
Filing time
17 May 2024, 16:05:17 UTC
Previous filing
26 Mar 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHGE Common Stock, par value $0.0001 per share Exercise of in-the-money or at-the-money derivative security $4,778 +4,778,265 +105% $0.001000* 9,330,580 15 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHGE Warrant to purchase common stock Exercise of in-the-money or at-the-money derivative security $0 -4,778,265 -100% $0.000000* 0 15 May 2024 Common stock 4,778,265 $0.001000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The warrant was exercisable beginning on February 27, 2023, for that number of shares that would not result in the Reporting Person beneficially owning more than 9.99% of the number of shares of common stock then issued and outstanding upon such exercise, and became exercisable in full on May 15, 2024. The warrant does not expire.